Kyoung-Sae Na

Prof. Kyoung-Sae Na

Gachon University, Incheon, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
YKYong-Ku Kim
Yong-Ku Kim
KNKyoung-Sae Na
Kyoung-Sae Na
AMAye-Mu Myint
Aye-Mu Myint
BLBrian E. Leonard
Brian E. Leonard

1 January 2014 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
KNKyoung-Sae Na
Kyoung-Sae Na
HJHan-Yong Jung
Han-Yong Jung
YKYong-Ku Kim
Yong-Ku Kim

Verified
Journal Article
Open access
PDF file
EWEunsoo Won
Eunsoo Won
KNKyoung-Sae Na
Kyoung-Sae Na
Yong-Ku KimYong-Ku Kim
Yong-Ku Kim
Pro-inflammatory systemic conditions that can cause neuroinflammation and subsequent alterations in brain regions involved in emotional regulation have been suggested as an underlying mechanism for the pathophysiology of major depressive disorder (MDD). A prominent feature of MDD is disruption of circadian rhythms, of which melatonin is considered a key moderator, and alterations in the melatonin system have been implicated in MDD. Melatonin is involved in immune system regulation and has been shown to possess anti-inflammatory properties in inflammatory conditions, through both immunological and non-immunological actions. Melatonin has been suggested as a highly cytoprotective and neuroprotective substance and shown to stimulate all stages of neuroplasticity in animal models. The ability of melatonin to suppress inflammatory responses through immunological and non-immunological actions, thus influencing neuroinflammation and neurotoxicity, along with subsequent alterations in brain regions that are implicated in depression, can be demonstrated by the antidepressant-like effects of melatonin. Further studies that investigate the associations between melatonin, immune markers, and alterations in the brain structure and function in patients with depression could identify potential MDD biomarkers.

1 January 2016 in Journal of Affective Disorders
Verified
Journal Article
Closed access
SCSeo-Eun Cho
Seo-Eun Cho
KNKyoung-Sae Na
Kyoung-Sae Na
SCSeong-Jin Cho
Seong-Jin Cho
JIJeong-Soo Im
Jeong-Soo Im
SKSeung-Gul Kang
Seung-Gul Kang

1 January 2018 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
YKYong-Ku Kim
Yong-Ku Kim
KNKyoung-Sae Na
Kyoung-Sae Na

1 November 2016 in Neuroscience Letters
Verified
Journal Article
Closed access
SCSeo-Eun Cho
Seo-Eun Cho
KNKyoung-Sae Na
Kyoung-Sae Na
SCSeong-Jin Cho
Seong-Jin Cho
SKSeung Gul Kang
Seung Gul Kang